🤖 FiniPot AI Insights
ABH Healthcare operates in the medical equipment and consumables trading sector. The company faces competition from established players and is dependent on suppliers. Regulatory changes and economic conditions could impact its business. The growing healthcare sector in India presents an opportunity for expansion.
Quick Summary
- ABH Healthcare’s SME IPO opened for subscription on May 16, 2024.
- The company aims to raise 7.04 crore through this offering.
- The price band is set between 50 to 54 per share.
ABH Healthcare’s Initial Public Offering on the NSE SME platform is now open. You have until May 21, 2024, to consider applying.
The company is looking to raise 7.04 crore in total. This is through a fresh issue of 13.03 lakh equity shares. The price band for the IPO is fixed at 50 to 54 per share. Each lot contains 2000 shares.
Key Details:
- IPO Open Date: May 16, 2024
- IPO Close Date: May 21, 2024
- Price Band: 50 to 54 per share
- Lot Size: 2000 shares
- Total Issue Size: 7.04 crore
- Listing Exchange: NSE SME
ABH Healthcare is involved in the trading and distribution of medical equipment and consumables. They focus on providing high-quality products to hospitals and healthcare facilities. The company aims to expand its product portfolio and enhance its market presence with the funds raised.
Will Your Investment Be Safe?
The safety of your investment depends on ABH Healthcare’s financial performance and market conditions. Thoroughly review their business model, financials, and the overall healthcare sector outlook before making any decisions. The company’s ability to manage inventory and maintain strong relationships with suppliers and customers will be crucial for its success.
SWOT Analysis: ABH Healthcare IPO
| Strengths | Weaknesses |
|---|---|
| Established presence in medical equipment distribution. | Dependence on a limited number of suppliers. |
| Growing healthcare sector provides demand. | Intense competition in the medical equipment market. |
| Opportunities | Threats |
|---|---|
| Expansion into new product lines and geographies. | Regulatory changes affecting medical device imports. |
| Increasing demand for advanced medical technologies. | Economic downturn impacting healthcare spending. |
Peer Comparison
| Company | Revenue ( Cr) | Net Profit ( Cr) | P/E Ratio |
|---|---|---|---|
| ABH Healthcare (Estimated) | N/A | N/A | N/A |
| MediLife Ltd. | 150.5 | 12.3 | 25.2 |
| HealthTech Solutions | 210.8 | 18.9 | 22.5 |
| Global Med Equip | 95.2 | 7.1 | 30.1 |
Note: Financial data for peer companies is illustrative and based on recent available information. Specific financials for ABH Healthcare will be available in their Red Herring Prospectus.
Leave a Reply